Thank you very much, Mr. Chair, and thank you to the members of the committee for having me here today.
I am Kimberly Carson. I'm the CEO of Breast Cancer Canada. It's the only national breast cancer organization focused on research, advocacy and education.
This year, as you may know, over 32,000 women will be diagnosed with breast cancer. Over 5,400 of them are going to die from this disease, which leaves us at about 15 women per day in this country. The numbers are still one in eight, and we have not yet seen a huge improvement on the number of deaths, compared to that one in eight.
For almost every one of those, the journey starts with screening and mammography. It's still our first line of defence for this disease. Those images are so important because they tell us where that woman is in the journey, how early on they are, whether or not they're going to need surgery, where their staging is, how accurate it is and how it's going to be treated. It's still very important as our first line of defence in this disease.
I want to leave you with something today. For women with breast cancer, it's not even about the wait to have the screening. It's about the wait through the entire system and what that actually means. It's from the screening and the diagnostics right straight through to the biopsy and the pathology reading. All of these pieces add to the delay and the wait time for a woman. Each one of them compounds the amount of time it takes for a woman to get her diagnosis and start her treatment.
The national data looks like this. The target is that 90% of women should receive a biopsy within seven weeks of that initial abnormal screening. Based on 2020 data from CPAC, the Canadian Partnership Against Cancer—this is the most up-to-date data, which is also a bit of a problem—the only province that's doing it is Alberta. It's a little bit of a problem when we're looking at that entire pathway and that entire screening pathway.
The question becomes, how does Alberta do it? How do we use the best practices here in Canada? Alberta has done it through a centralized diagnostic lab system. It's working. On top of that, we have an eastern Ontario network of 16 hospitals right here in the national capital region that are working together. Again, we're getting the results faster, so there are some Canadian ways that are able to do some of this stuff.
The Canadian Association of Radiologists, which is going to speak today, is saying that one-third of our equipment in Canada is really dated—it's over 10 years old—making that even more difficult to deal with when we're trying to get women through these systems. Then the systems don't talk to each other.
These are all things that we've spoken about, but the screening from mammography really matters. Women are able now to self-refer at the age of 40 in most provinces. We're still asking for the national guidelines to be changed to 40—they have yet to be lowered to the age of 40—to help us work through this system with women, because we know that the sooner we catch it, the better the outcomes.
There are a few things I think we can do at the federal level.
The first is to measure the whole patient journey. Breast Cancer Canada has developed a PROgress Tracker, which tracks the patient's journey from beginning to end. We track them for 10 years. We can certainly scale that up nationally across this country to help with the data and give more timely data. It's the data from patients. It's a self-referred study that patients can enter anywhere and anytime. I'm pleased to say that right now, after running it for a couple of years, we have every province and territory represented in our database. However, it certainly needs to be scaled.
Secondly, we obviously need to invest in more equipment.
Third, we need more innovation. We're looking at new innovation that's coming. We have blood tests and breath tests coming, which may help reduce the burden on the system. If we can do a blood test or a breath test up front and know that a woman needs a mammogram more frequently, or if we can use AI to predict it, then do we actually have to send as many women for mammograms as frequently? I think there's going to be more technology.
Then, obviously, we're looking for the age to be lowered to 40.
